Harrow Stock

Harrow Current Liabilities

The Current Liabilities of Harrow (HROW) as of Aug 9, 2026 is 155.67 M USD. In the previous year, Current Liabilities was 143.84 M USD — a change of 8.23% (higher).

Current Liabilities

155.67 MUSD

YoY

8.23%

Last updated:

Current Liabilities of Harrow is 2026 155.67 M USD. Current Liabilities of Harrow was 2025 143.84 M USD. It decreases by 8.23% higher compared to the previous year.
Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

Current Liabilities of Harrow is 155.67 M USD in 2026.

Current Liabilities of Harrow changed from 143.84 M USD to 155.67 M USD, representing a 8.23% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Harrow since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Harrow historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Harrow

All Key Metrics — Harrow